1470408328882835467

Today at the @ASH_hematology Annual Meeting & Exposition, we will share 2-year outcomes and updates on our Phase 1 study of GDA-201 in combination with rituximab in patients with non-Hodgkin lymphoma.

Learn more here: https://t.co/CqDKW33SIU

#ASH21 https://t.co/pgBgXQW97J